Anavex Life Sciences (AVXL) Cash from Operations Growth (1y) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 85.14% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 74.39% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.23% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 158.60% |
| 10 | Anavex Life Sciences | 266.20 Mn | 134.45 Mn | - | 41.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 41.00% |
| Sep 30, 2025 | -29.23% |
| Jun 30, 2025 | -140.62% |
| Mar 31, 2025 | 49.76% |
| Dec 31, 2024 | -65.62% |
| Sep 30, 2024 | -13.83% |
| Jun 30, 2024 | 32.31% |
| Mar 31, 2024 | -37.31% |
| Dec 31, 2023 | -26.30% |
| Sep 30, 2023 | -44.63% |
| Jun 30, 2023 | -8.50% |
| Mar 31, 2023 | 11.94% |
| Dec 31, 2022 | -65.50% |
| Sep 30, 2022 | 47.31% |
| Jun 30, 2022 | 6.22% |
| Mar 31, 2022 | -31.74% |
| Dec 31, 2021 | 55.52% |
| Sep 30, 2021 | -22.70% |
| Jun 30, 2021 | -85.97% |
| Mar 31, 2021 | -39.03% |
| Dec 31, 2020 | -37.49% |
| Sep 30, 2020 | -146.80% |
| Jun 30, 2020 | 46.09% |
| Mar 31, 2020 | -21.50% |
| Dec 31, 2019 | -37.62% |
| Sep 30, 2019 | 37.47% |
| Jun 30, 2019 | -259.23% |
| Mar 31, 2019 | -53.55% |
| Dec 31, 2018 | -14.92% |
| Sep 30, 2018 | -84.92% |
| Jun 30, 2018 | 29.79% |
| Mar 31, 2018 | -304.30% |
| Dec 31, 2017 | -14.79% |
| Sep 30, 2017 | -17.64% |
| Jun 30, 2017 | -33.73% |
| Mar 31, 2017 | 63.33% |
| Dec 31, 2016 | 2.88% |
| Sep 30, 2016 | -29.99% |
| Jun 30, 2016 | -55.48% |
| Mar 31, 2016 | -183.84% |
| Dec 31, 2015 | -368.52% |
| Sep 30, 2015 | -56.33% |
| Jun 30, 2015 | -48.99% |
| Mar 31, 2015 | -92.87% |
| Dec 31, 2014 | -59.33% |
| Sep 30, 2014 | -89.23% |
| Jun 30, 2014 | -2,882.31% |
| Mar 31, 2014 | -168.77% |
| Dec 31, 2013 | -230.61% |
| Sep 30, 2013 | -92.32% |
| Jun 30, 2013 | 86.51% |
| Mar 31, 2013 | -13.24% |
| Dec 31, 2012 | 87.91% |
| Sep 30, 2012 | 72.69% |
| Jun 30, 2012 | 80.21% |
| Mar 31, 2012 | 80.61% |
| Dec 31, 2011 | -0.38% |
| Sep 30, 2011 | 44.54% |